Compare FLL & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLL | VANI |
|---|---|---|
| Founded | 1987 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 98.3M | 100.0M |
| IPO Year | 2014 | 2014 |
| Metric | FLL | VANI |
|---|---|---|
| Price | $2.68 | $1.21 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $4.00 | $3.50 |
| AVG Volume (30 Days) | ★ 241.0K | 153.0K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.45 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $302,376,000.00 | $4,000,000.00 |
| Revenue This Year | $7.54 | N/A |
| Revenue Next Year | $6.49 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 3.53 | N/A |
| 52 Week Low | $2.02 | $0.92 |
| 52 Week High | $4.95 | $1.92 |
| Indicator | FLL | VANI |
|---|---|---|
| Relative Strength Index (RSI) | 49.04 | 54.11 |
| Support Level | $2.24 | $1.21 |
| Resistance Level | $2.98 | $1.25 |
| Average True Range (ATR) | 0.21 | 0.06 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 31.63 | 58.54 |
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins. Geographically, it operates in United States.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.